Hippocampal Volumes in Youth With Type 1 Diabetes by Hershey, Tamara et al.
Hippocampal Volumes in Youth With Type 1 Diabetes
Tamara Hershey,
1,2,3 Dana C. Perantie,
1 Jenny Wu,
1 Patrick M. Weaver,
1 Kevin J. Black,
1,2,3,4 and
Neil H. White
5,6
OBJECTIVE—Hippocampal neurons in adult animals and hu-
mans are vulnerable to severe hypoglycemia and hyperglycemia.
Effects are hypothesized to be exacerbated during development,
but existing studies on developing human brains are limited. We
examined whether hypoglycemia or hyperglycemia experienced
during brain development in humans affects hippocampal
volumes.
RESEARCH DESIGN AND METHODS—We analyzed T1-
weighted magnetic resonance images in 95 youth with type 1
diabetes and 49 sibling control subjects aged 7–17 years. Youth
with diabetes were categorized as having 0 (n  37), 1–2 (n 
41), or 3 or more (3; n  17) prior severe hypoglycemic
episodes. Hyperglycemia exposure was estimated from median
lifetime A1C, weighted for duration of diabetes. Stereologic
measurements of hippocampal volumes were performed in atlas-
registered space to correct for whole brain volume.
RESULTS—Greater exposure to severe hypoglycemia was as-
sociated with larger hippocampal volumes (F [3,138]  3.6, P 
0.016; 3 larger than all other groups, P  0.05). Hyperglycemia
exposure was not associated with hippocampal volumes (R
2
change  0.003, F [1,89]  0.31, P  0.58, semipartial r  0.06;
one outlier removed for high median A1C), and the 3 severe
hypoglycemia group still had larger hippocampal volumes after
controlling for age of onset and hyperglycemia exposure (main
effect of hypoglycemia category, F [2,88]  6.4, P  0.002; 3
larger than all other groups, P  0.01).
CONCLUSIONS—Enlargement of the hippocampus may reﬂect
a pathological reaction to hypoglycemia during brain develop-
ment, such as gliosis, reactive neurogenesis, or disruption of
normal developmental pruning. Diabetes 59:236–241, 2010
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europathological data from adult animals sug-
gest that severe hypoglycemia may preferen-
tially harm neurons in the medial temporal
region, including the hippocampus (1,2). The
degree of hippocampal damage increases with duration of
hypoglycemia and with the presence of seizures (3–5). In
contrast, the cerebellum appears to be relatively spared by
hypoglycemia (6). This pattern of selective vulnerability
has been reported in neuropathological studies of adult
animals and humans (3,4,6) and on visual inspection of
clinical brain scans of adult humans with type 1 diabetes
(2,7). Cell death during hypoglycemia is thought to be
caused by an N-methyl-D-aspartate (NMDA) receptor–
mediated excitotoxic process; hippocampal sensitivity
may be (8) explained by the relatively high proportion of
NMDA receptors in that region (8). However, there may be
other mechanisms by which hypoglycemia affects neurons
in the hippocampus, such as apoptosis (9).
Animal studies of hypoglycemic effects on the develop-
ing hippocampus have been limited. However, neither of
two relevant studies found increased neuronal death in the
hippocampus after moderate hypoglycemia in young rats
(10,11). Notably, these studies did ﬁnd signiﬁcant cell
death in cortical regions, which could correspond to the
regional cortical volume loss observed in voxel-wise neu-
roimaging analyses of youth with type 1 diabetes (12).
Although it is possible to measure the volume of the
hippocampus reliably and detect even subtle atrophy in
this structure in children with temporal lobe epilepsy,
anoxia, and other medial temporal lobe insults (13), ex-
aminations of the effects of hypoglycemia on the hip-
pocampus using quantitative neuroimaging methods have
been limited. One recent study reported an increased
incidence of medial temporal sclerosis in diabetic children
with early hypoglycemia (before 6 years of age) compared
with those with later hypoglycemia (6 years or older), but
not compared with those with no hypoglycemia history. In
addition, no differences were found in absolute hippocam-
pal volumes across these small groups. However, no
correction for whole brain volume was performed and
no control group was assessed (14). Interestingly, studies
on children with temporal lobe seizures have found that
early exposure to seizures can cause greater long-term
memory deﬁcits (15) and greater hippocampal damage
(16–18) than seizures that occur during adulthood.
The possibility of acute severe hypoglycemia occurs
within a context of chronic hyperglycemia, which may
have its own effects on brain integrity. In fact, studies have
found that hyperglycemia is related to decreased hip-
pocampal gray matter in adults with type 2 diabetes (19)
and possibly decreased hippocampal function in adult
animal models (20,21). However, previous studies have
not been able to disentangle the effects of severe hypogly-
cemia and chronic hyperglycemia exposure during devel-
opment on the hippocampus in humans with type 1
diabetes. Further understanding of the effects of exposure
to glycemic extremes on the hippocampus in development
may provide critical information for minimizing risks and
maximizing clinical beneﬁts over a patient’s childhood. In
this study, we acquired structural magnetic resonance
imaging (MRI) and glycemic history from a large sample of
youth with type 1 diabetes and nondiabetic siblings who
have already been characterized cognitively (22). We com-
From the
1Department of Psychiatry, Washington University School of Medi-
cine, St. Louis, Missouri; the
2Department of Neurology, Washington Uni-
versity School of Medicine, St. Louis, Missouri; the
3Department of
Radiology, Washington University School of Medicine, St. Louis, Missouri;
the
4Department of Anatomy and Neurobiology, Washington University
School of Medicine, St. Louis, Missouri; the
5Department of Pediatrics,
Washington University School of Medicine, St. Louis, Missouri; and
6St.
Louis Children’s Hospital, St. Louis, Missouri.
Corresponding author: Tamara Hershey, tammy@wustl.edu.
Received 29 July 2009 and accepted 22 September 2009. Published ahead of
print at http://diabetes.diabetesjournals.org on 15 October 2009. DOI: 10.
2337/db09-1117.
© 2010 by the American Diabetes Association. Readers may use this article as
long as the work is properly cited, the use is educational and not for proﬁt,
and the work is not altered. See http://creativecommons.org/licenses/by
-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked “advertisement” in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
See accompanying commentary, p. 4.
ORIGINAL ARTICLE
236 DIABETES, VOL. 59, JANUARY 2010 diabetes.diabetesjournals.orgpared diabetic and control groups and examined the
association of hippocampal volumes, measured with vali-
dated and unbiased stereologic methods, with previous
histories of severe hypoglycemia and chronic hyperglyce-
mia exposure.
RESEARCH DESIGN AND METHODS
Subjects. Children aged 7–17 years with type 1 diabetes and nondiabetic
siblings (control subjects) were recruited from the Pediatric Diabetes Clinic at
Washington University in St. Louis and St. Louis Children’s Hospital. Subjects
were excluded for mental retardation, chronic disease other than type 1
diabetes (e.g., hypothyroidism), signiﬁcant neurological history not due to
diabetes, diagnosed psychiatric disorder, current use of psychoactive medi-
cations, prematurity (less than 36-week gestation) with complications, and
contraindications to MRI (e.g., metal implants). Diabetic subjects had to have
been on insulin for at least 2 years prior to study entry. Handedness was
assessed with a modiﬁed Edinburgh Handedness Inventory (23). Procedures
were approved by the Washington University School of Medicine’s Human
Studies Committee, and all participants and their parents or guardians signed
informed consents. Data from this cohort of children have been published
previously (12,22). Hippocampal analyses reported here have not been pub-
lished previously except in abstract form.
Clinical variables. History of severe hypoglycemia was collected by simul-
taneous parental and child interview. All incidents described were counted,
regardless of who remembered the details. Severe hypoglycemia was deﬁned
similarly to Diabetes Control and Complications Trial criteria and our
previous reports (12,22,24). This deﬁnition states that hypoglycemic events
are severe when there are symptoms consistent with hypoglycemia and
neurological dysfunction including seizure, loss of consciousness, or inability
to arouse from sleep or individuals need assistance to treat their hypoglycemia
and there is a documented response to oral or parenteral glucose or glucagon
treatment (24). Due to the skewed distribution of the number of hypoglycemic
events, we categorized individuals as having 0, 1–2, or 3 or more (3) severe
hypoglycemic events in their past. The age at ﬁrst severe hypoglycemic event was
noted. Those with a ﬁrst episode occurring when they were 5 years or younger
were considered “early” and those with a ﬁrst episode occurring at older than 5
years were “late,” consistent with other work (25).
Chronic exposure to hyperglycemia was calculated by collecting all
available A1C test results from medical records at Pediatric Diabetes Clinic at
Washington University in St. Louis and St. Louis Children’s Hospital. The
amount of time represented by the A1C tests was calculated by multiplying the
number of tests by 3 months, the time frame reﬂected in each test, and
dividing by duration of the individual’s diabetes in months. To minimize the
effect of incomplete data and to eliminate outliers from analyses, participants
with A1C “coverage” less than 30% of their duration of diabetes (n  10) were
excluded. To account for duration of exposure to hyperglycemia, a “hyperglyce-
mia exposure score” was calculated. Median A1C and duration variables were
transformed to z scores, and each patient’s pair of z scores was summed (A1C z
score  duration z score). This method of calculation resulted in a near-normal
distribution of hyperglycemia exposure scores, with higher scores indicating
more overall exposure to hyperglycemia; however, these scores can be inter-
preted to indicate hyperglycemia exposure only relative to this sample.
Image acquisition. Structural MRIs were acquired for each subject on a
Siemens Sonata 1.5 Tesla imaging system with a standard Siemens 30-cm
circularly polarized radiofrequency (RF) head coil. For each subject, three to
ﬁve scans consisting of 128 contiguous 1.25-mm sagittal slices were acquired
using magnetization prepared rapid gradient echo (MPRAGE; repetition time
[TR]  1,900 ms, echo time [TE]  3.93 ms, ﬂip angle  15°, matrix  256 
256 pixels, voxel size  1  1  1.25 mm, single scan time  7 min, 7 s).
Subjects with movement or other artifact were excluded from further analyses
(n  10). Images with suspected anatomical abnormalities were referred to a
neuroradiologist for review; three subjects were excluded for conﬁrmed brain
abnormalities (two were benign anomalies but discarded due to possible
difﬁculty with registration).
Image preprocessing. The three highest quality images were coregistered by
an automated, validated technique (26,27), averaged for each subject and atlas
transformations computed. We used a target image composed of 24 brains—
one for every age and sex between the ages of 7 and 18 years—made to
represent the atlas of Talairach and Tournoux (28) as modiﬁed by Lancaster
et al. (29). The coregistered, averaged, atlas-transformed data were resampled
to a standard, 0.5-mm cubic voxel volume in which the long axis of the
hippocampus was perpendicular to the coronal plane (30). Stereology pro-
ceeded as described below and previously (31) except that the anatomy was
stretched in conformity with the atlas, making the measurements “relative”
volumes (i.e., corrected for whole brain volume). Because the atlas transfor-
mation is afﬁne, measured (relative) versus absolute volumes are related by a
known multiplicative factor (the determinant of the transform matrix or atlas
scaling factor [ASF]) that is constant over the entire volume. Thus, we can
compute the absolute volume of the hippocampus from the relative volumes
after it has been measured. Previous work has shown that the ASF is
equivalent to manual measures of total intracranial volume and that computed
absolute hippocampal volume is equivalent to direct measurement of the
hippocampus in native space (32). Performing stereologic measures in a
standard space avoids errors due to inconsistent structure boundary selection
(e.g., amygdala/hippocampus) that otherwise occur due to variability of brain
size and head orientation (33).
Stereologic method and reliability. Stereologic methods (34) were used to
estimate hippocampal volumes using Analyze (Biomedical Imaging Resource,
Mayo Foundation, Rochester, NY). In stereology, a grid of points is randomly
placed on a brain slice. Points that fall within a structure of interest are
selected. The number of these points times the grid dimensions (length, width,
height) is mathematically proven to produce an unbiased estimate of volume
(35). While selecting the points, orthogonal views of that point were examined
in Analyze for better anatomical identiﬁcation. Sampling parameters and grid
size were set to yield 150 selected grid points per hippocampus, a number
that has previously been determined to yield reliable measurements in brain
volume determination (36). Measures were performed on coronal slices every
ﬁve slices (2.5 mm) within a three-dimensional MRI cubical subvolume
composed of 0.5  0.5  0.5–mm voxels (Fig. 1). Starting slice was randomly
determined for each measurement, an essential step in guaranteeing that the
volume measurements are unbiased (34,35). The process is identical to
previously published methods (31), with one exception. Instead of randomly
placing the grid once per brain, we generated random grid angle and starting
positions on every slice, thus taking advantage of the reduced variance
(increased precision) this procedure provides (36). Raters were blind to
subject identity and measured left and right hippocampal volumes separately.
Mean left and right hippocampal volumes were determined from an average of
four measurements of each volume, two measurements from each rater.
Average measures intraclass correlations (two-way mixed, absolute agree-
ment) between each rater pair were above 0.94 for total hippocampal volume.
Anatomical boundaries of the hippocampus were deﬁned using speciﬁc rules
(37,38) and applied as previously described (31).
Analyses. To determine the relationship between hippocampal volume and
diabetes, hypoglycemia, and hyperglycemia, we performed both repeated-
measures general linear models and hierarchical linear regressions controlling
for age and sex, and for analyses of diabetic groups only, age of onset.
Hypoglycemia exposure was examined by comparing hypoglycemia frequency
subgroups (0, 1–2, vs. 3). Hyperglycemia was examined using our hypergly-
cemia exposure variable. The primary dependent measures were total relative
and absolute hippocampal volumes and ASF as an index of total intracranial
volume. For signiﬁcant effects or interactions, post hoc correlations and
2-sample comparisons (t tests) were performed.
RESULTS
Type 1 diabetic subjects versus nondiabetic control
subjects. Ninety-ﬁve youth with type 1 diabetes and 49
nondiabetic siblings had adequate imaging and glycemic
FIG. 1. Example of the stereologic method for measuring hippocampal
volumes. Selected points (black) were determined to be within the left
hippocampal gray matter on a coronal view (shown), while simulta-
neously viewed in the sagittal and transverse perspectives.
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jects, there was no relationship between age and the ASF
(indicating total intracranial volume [32]) (r  0.13, P 
0.11) or age and absolute total hippocampal volume (r 
0.04, P  0.66). There was a very modest but nonsignif-
icant correlation between age and relative hippocampal
volume (r  0.16, P  0.06). Absolute hippocampal
volumes (t  2.77, P  0.006) and ASF (t  7.38, P 
0.001) were greater for males (n  79) compared with
females (n  65). However, males had smaller relative
hippocampal volumes than females (males, mean vol-
ume  4,994 mm
3, females mean volume  5,195 mm
3;t
2.24, P  0.03). To ensure that age and sex would not
inﬂuence our other results, we covaried both factors from
subsequent analyses.
Youth with type 1 diabetes and nondiabetic siblings did
not differ signiﬁcantly in sex distribution (
2  0.44, P 
0.51) or mean age (t  0.01, P  0.99). The diabetic group
had proportionally more left-handed or ambidextrous sub-
jects than the nondiabetic group (
2  3.85, P  0.05).
Because almost all of the non–right-handed individuals
were within the diabetic group (11/95 vs. nondiabetic
1/49), we examined signiﬁcant effects with and without
these individuals. Results were the same regardless of the
inclusion or exclusion of non–right-handed individuals.
Controlling for age and sex, groups did not differ in whole
brain volumes (F [1,140]  1.06, P  0.31) or total
hippocampal volume (absolute, F [1,140]  1.22, P  0.27;
relative, F [1,140]  0.34, P  0.56).
Hypoglycemia and hyperglycemia. Within the group of
95 youth with diabetes, 37 subjects had no severe hypo-
glycemia in the past (0 hypo), 41 experienced 1–2 severe
hypoglycemic episodes (1–2 hypo; mean number of epi-
sodes  1.2, SD  0.4), and 17 had three or more severe
hypoglycemic episodes in the past (3 group; mean num-
ber of episodes  9.2, SD  11.2; mean without individual
with 50 episodes  6.7, SD  2.8). Mean age did not differ
across these groups or compared with nondiabetic siblings
(F [1,140]  0.32, P  0.81). Sex (
2  4.3, P  0.23) and
handedness (
2  5.1, P  0.17) distributions were also
similar across subgroups (Table 1).
The total number of hypoglycemic events characterized
as severe was 205 (within subjects with any past hypogly-
cemia, mean  3.5, SD  6.9, range  1–50; excluding the
individual with 50 episodes, mean  2.7, SD  3.1, range 
1–15). All episodes involved the inability to self-treat and
successful response to glucose or glucagon treatment (20
or 9.8% with glucagon shots, 16 or 7.8% with intravenous
glucose administration, and the rest with food or drink).
Most (179 or 87.3%) episodes had reported neurological
symptoms (e.g., incoherence, hallucinations, hemiparesis,
disorientation, failure to arouse, impaired speech, disco-
ordination, seizures [79 or 38.5%], or loss of consciousness
[91 or 44.4%]). Those episodes without reported clear
neurological symptoms had veriﬁed low glucose levels or
other somatic symptoms including vomiting, dizziness,
shakiness, and slowed breathing.
Hypoglycemia frequency subgroups did not differ from
each other or from nondiabetic siblings in ASF (F [3,138] 
0.57, P  0.64). However, groups did differ in absolute (F
[3,138]  2.9, P  0.036) and relative (F [3,138]  3.6, P 
0.016) total hippocampal volumes. Because this effect was
consistent for both relative and absolute hippocampal
volumes and relative volumes are corrected for whole
brain size, we report from here forward on relative hip-
pocampal volumes only. Post hoc comparisons for relative
hippocampal volumes revealed that the 3 subgroup had
signiﬁcantly larger relative hippocampal volume than all
other groups, including sibling control subjects (P  0.02)
(Fig. 2A). When considering only subjects with diabetes
and additionally controlling for age of onset, this effect
was strengthened (F [2,89]  6.7, P  0.002; 3 larger than
0 and 1–2 hypo groups, P  0.006). This effect was
consistent across left (effect of group, F [2,89]  6.7, P 
0.002; 3 greater than 0 and 1–2 hypo groups, P  0.003)
and right (effect of group, F [2,89]  6.2, P  0.003; 3
greater than 0 and 1–2 hypo groups, P  0.02) hippocam-
pal volumes (Table 1).
To determine whether other characteristics of hypogly-
cemia besides frequency category (0, 1–2, 3 episodes)
were also associated with total relative hippocampal vol-
umes, we explored the impact of timing (whether any
hypoglycemia episodes occurred before or after age 5
years) and severity (whether any episodes involved sei-
zures or loss of consciousness) on volumes. Within partic-
ipants who had experienced a severe hypoglycemic
TABLE 1
Demographic and clinical variables
Nondiabetic control
subjects
Type 1 diabetic subjects
Total
sample 0 hypo 1–2 hypo 3 hypo
n 49 95 37 41 17
Age (years) 12.4  2.7 12.4  2.8 12.1  2.4 12.5  2.8 12.9  3.3
Female subjects 49 43 38 39 65
Right handed 98 88 89 85 94
Age of onset (years)* — 7.1  3.2 8.5  2.6 6.8  3.2 4.7  3.2
Duration of diabetes (years)* — 5.4  2.8 3.7  1.3 5.8  2.6 8.1  2.9
Median A1C — 8.3  1.0 8.2  1.2 8.3  0.8 8.7  0.9
Hyperglycemia exposure score* — 0  1.4 0.76  1.2 0.10  1.1 1.48  1.2
Atlas scaling factor (unitless) 0.86  0.08 0.87  0.08 0.89  0.08 0.88  0.08 0.86  0.07
Total absolute 4,339  607 4,417  541 4,487  485 4,337  462 4,680  578
Hippocampal volume (mm
3)
Total relative hippocampal volume† 5,056  581 5,085  541 5,076  492 4,965  474 5,475  545
Right relative hippocampal volume 2,546  307 2,577  286 2,599  254 2,515  251 2,773  300
Left relative hippocampal volume 2,510  285 2,507  267 2,477  252 2,450  234 2,702  285
Data are means  SD or percent unless otherwise indicated. *All hypoglycemia subgroups are different from each other (P  0.05). †3
hypoglycemia group is different from all other subgroups (P  0.05).
HIPPOCAMPAL VOLUMES IN TYPE 1 DIABETIC YOUTH
238 DIABETES, VOL. 59, JANUARY 2010 diabetes.diabetesjournals.orgepisode in the past, there was no effect of age of ﬁrst
episode (younger than 5 years vs. older than 5 years; F
[1,51]  0.06, P  0.81) or interaction between age of ﬁrst
episode category and frequency category (F [1,51]  0.06,
P  0.81) on total relative hippocampal volume. Likewise,
the presence of seizures or loss of consciousness did not
inﬂuence hippocampal volume (F [1,51]  0.99, P  0.32),
and there was no interaction between presence of seizures
or loss of consciousness and frequency category on hip-
pocampal volume (F [1,51]  0.23, P  0.63). Finally, a
history of diabetic ketoacidosis did not inﬂuence hip-
pocampal volumes (P  0.53), and controlling for history
of diabetic ketoacidosis did not alter the effect of hypo-
glycemia frequency on hippocampal volumes (P  0.025).
To address the possibility of sex confounding the hypo-
glycemia frequency subgroups (nonsigniﬁcantly higher
proportion of females in the 3 group; Table 1), a second-
ary analysis within each sex category was performed
separately. The effect of hypoglycemia subgroup (control-
ling for age and age of onset) was still signiﬁcant in both
the female-only subset (F [2,36]  3.4, P  0.04) and the
male-only subset (F [2,49]  3.6, P  0.03), despite lower
sample sizes and reduced power.
After excluding subjects with A1C coverage of 30%,
the remaining subjects had a normally distributed distri-
bution of coverage, with an average of 68% (SD  14) of
their duration of diabetes covered by existing A1C values.
Hyperglycemia exposure scores (median A1C weighted for
duration of diabetes) differed across hypoglycemia sub-
groups (F [2,92]  20.3, P  0.001), and all groups were
signiﬁcantly different from one another (P  0.003; Table
1). However, duration of diabetes (F [2,92]  23.7, P 
0.001) but not median A1C (F [2,92]  1.9, P  0.16) also
differed across groups in a similar fashion (Table 1),
suggesting that this effect was largely, but not exclusively,
driven by the earlier age of onset of the 3 hypoglycemia
group. Regardless, when each of these confounding vari-
ables (median A1C, duration, and age of onset) was
covaried, the effect of hypoglycemia frequency on relative
hippocampal volumes remained signiﬁcant (P  0.005).
Within the entire diabetic sample, hyperglycemia expo-
sure was not associated with relative hippocampal volume
after controlling for age, sex, and age of onset (R
2
change  0.003, F [1,89]  0.31, P  0.58, semipartial r 
0.06; one outlier removed for high median A1C) (Fig. 2B).
Among diabetic participants without any severe hypogly-
cemia in their past, hyperglycemia exposure also did not
correlate with hippocampal volumes (R
2  0.02, F [1,31] 
0.73, P  0.40).
DISCUSSION
Greater exposure to severe hypoglycemia during child-
hood was associated with enlargement of hippocampal
gray matter volume in youth with type 1 diabetes. This
effect was not explained by age, sex, degree of hypergly-
cemia exposure, age of onset, or duration of disease and
was equivalent for both hemispheres. Although the direc-
tion of the effect was unexpected, the fact that the subset
of youth with three or more severe hypoglycemic episodes
in their past was different from all other groups, including
sibling control subjects, supports the sensitivity of the
hippocampus to effects of repeated hypoglycemic epi-
sodes during brain development. These data do not sup-
port the idea that chronic hyperglycemia in childhood
affects gray matter volume in the hippocampus.
These ﬁndings are in contrast to the existing, although
limited, data on adults with diabetes. Case studies of
adults who suffered profoundly severe hypoglycemia have
reported distinct neuronal death in the hippocampus bi-
laterally (1,2,7,39). However, one study in adults with type
1 diabetes found that hippocampal volumes were compa-
rable with control subjects (1) (n  13). Given the small
sample sizes in that study, statistical power likely limited
the ability to detect differences in hippocampal volumes.
In contrast, a slightly larger study of adults with type 2
diabetes (n  23) found reduced hippocampal volume
compared with control subjects and a correlation between
hyperglycemia exposure and degree of volume loss (40).
Thus, there is no precedent in the adult literature for
increased volume of the hippocampus in association with
diabetes, hyperglycemia, or hypoglycemia.
The single study using quantiﬁed hippocampal volumes
in children with type 1 diabetes compared those with
versus without hypoglycemia-related seizures and those
with early versus late hypoglycemia-related seizures on
whole brain gray matter volume and absolute hippocampal
volume (14). No control group was assessed. They found
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pocampal volumes, but total gray matter volume did tend
to be smaller in youth with previous seizures. Thus, if
relative hippocampal volumes had been calculated, it is
possible that larger relative hippocampal volumes in those
with hypoglycemia-related seizures would have been ob-
served. Notably, our study found both enlarged absolute
and relative hippocampal volumes in those with multiple
severe hypoglycemic episodes. Other differences in the
methodology of that study, such as very strict deﬁnition of
severe hypoglycemia, failure to correct for sex effects, and
relatively small sample sizes, make direct comparisons
with our ﬁndings difﬁcult.
Interestingly, there is a precedent for abnormal enlarge-
ment of the hippocampus in other developmental disor-
ders. Hippocampal enlargement has been noted in children
with fragile X syndrome (41), autism, and attention-deﬁcit
hyperactivity disorder (ADHD). For example, Plessen et
al. (42) found increased hippocampal volumes in children
with combined type ADHD (n  51; 6–18 years old)
compared with control subjects (n  63). However, within
the ADHD group, increased symptoms were associated
with smaller hippocampi volumes. The authors speculate
that the enlargement could thus reﬂect a compensatory
response to ADHD; this is supported by “abundant preclin-
ical evidence for the presence of synaptic remodeling and
neurogenesis within the hippocampus ...i nresponse to
experiential demands.” Enlargement of the hippocampus
has also been reported in children (7.5–18.5 years of age)
with autism, both with and without mental retardation
compared with control subjects but not in adults with
autism (43). The authors suggest that this could be due to
“use-dependent expansion of hippocampal connections”
or pathological development, perhaps because of reduced
programmed cell death (44,45).
Based on these reports and the explanations that are
proposed, we speculate that enlargement of the hippocam-
pus in our study could reﬂect a pathological reaction to
repeated severe hypoglycemia during development such
as gliosis, disruption of normal developmental pruning or
reactive neurogenesis, or a compensatory developmental
response to injured neurons. There is little relevant exper-
imental evidence addressing possible mechanisms of al-
tered hippocampal volume in response to hypoglycemia.
Estrada et al. (46) reported increased transient glial reac-
tivity followed by prolonged and enhanced neurogenesis
in the hippocampus after hypoglycemia, but these studies
were performed in adult rats. In contrast, Yamada et al.
(10) found no change in neurogenesis in the hippocampal
dentate granule cell region after moderate hypoglycemia
in immature rats, suggesting that this mechanism may not
be responsible for our results. Further animal experimen-
tation would be necessary to address other possible
mechanisms of hippocampal enlargement in response to
hypoglycemia during development.
Our data in a large sample indicate that there is no
signiﬁcant relationship between degree of hyperglycemia
exposure and hippocampal volumes. This stands in con-
trast to some animal work, suggesting that neurons in the
hippocampi of immature animals are more affected by
hyperglycemia than hypoglycemia (47). Perhaps greater
severity or duration of hyperglycemia exposure is neces-
sary for changes in the hippocampal structure to be
detected during development. Importantly, the lack of a
relationship between hyperglycemia and volume does not
rule out the possibility of functional effects of hyperglyce-
mia within the hippocampus. Studies using functional MRI
or other functional imaging measures would be needed to
test this possibility.
These ﬁndings highlight the possibility that metabolic
insults that occur during development can have a qualita-
tively different impact on brain structure than those oc-
curring in a fully mature system. For example, early
damage to the hippocampus and surrounding medial tem-
poral region can produce long-term memory deﬁcits, sim-
ilar to those found in adults, but can also induce unique
social and cognitive deﬁcits (e.g., response inhibition)
generally associated with prefrontal dysfunction in adults
(48–50). Researchers have speculated that these effects
could be due to developmental disruption of connections
between the hippocampal region and the prefrontal cortex
(48–50). As noted by Ennis et al. (11), differential effects of
metabolic insults on the brain depending on age could be
explained by the developmental stage of the cells affected
or changes in the density or function of neurotransmitter
receptors.
This highly focused study tested hypotheses about the
effects of hypoglycemia and hyperglycemia during devel-
opment on the gray matter of the hippocampus. Because
of this focus, we cannot address possible effects in white
matter of the hippocampus or other gray or white matter
regions of the brain. In addition, the function of hippocam-
pus could be affected in addition to or in the absence of
structural change. Due to limitations in the resolution and
methods of MRI, we cannot distinguish among possible
mechanisms of structural change. Finally, our cross-
sectional study would be complemented by prospective
measurement of hippocampal volume and more detailed
analyses of hippocampal shape or subﬁeld volume changes
over time. Future analyses may also take into account
behavioral and cognitive correlates of hippocampal differ-
ences. However, our study reports on the largest sample of
youth with type 1 diabetes assessed with highly reliable,
unbiased, and gold standard measures of hippocampal
gray matter volume. Using these powerful techniques, we
found an intriguing pattern of results that must be taken
into account in neurodevelopmental theories of the brain’s
response to insults. In addition, our ﬁndings support the
idea of a special relationship between hypoglycemia and
the hippocampus during development.
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